Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 1 - 50 av 127 resultater
Tid
Selskap
Tittel
Sektor
Kategori
21 May 2024
18:00 CEST
THERAVET
TheraVet Announces Early Completion of Patient Recruitment of the VISCO-VET Clinical Study
20103015 Pharmaceuticals
Other subject
21 May 2024
18:00 CEST
THERAVET
TheraVet annonce la fin anticipée du recrutement des patients de l'étude clinique VISCO-VET
20103015 Pharmaceuticals
Other subject
07 May 2024
07:30 CEST
THERAVET
TheraVet dévoile sa stratégie de développement pour le marché équin
20103015 Pharmaceuticals
Other subject
07 May 2024
07:30 CEST
THERAVET
TheraVet Unveils Its Development Strategy to Address the Equine Market
20103015 Pharmaceuticals
Other subject
23 Apr 2024
07:30 CEST
THERAVET
TheraVet reports Full-Year 2023 Financial Results and Provides the Preparatory Documents for the General Meeting of June 6th, 2024
20103015 Pharmaceuticals
Income
23 Apr 2024
07:30 CEST
THERAVET
TheraVet publie ses résultats annuels pour l’exercice 2023 et met à disposition les documents préparatoires pour l’Assemblée Générale du 6 juin 2024
20103015 Pharmaceuticals
Income
10 Apr 2024
07:30 CEST
THERAVET
TheraVet Reports 2023 Full Year and 2024 First Quarter Revenues
20103015 Pharmaceuticals
Sales
10 Apr 2024
07:30 CEST
THERAVET
TheraVet publie son chiffre d’affaires pour l’exercice 2023 et pour le premier trimestre 2024
20103015 Pharmaceuticals
Sales
13 Mar 2024
08:55 CET
THERAVET
TheraVet : BIOCERA-VET® est désormais disponible pour la prise en charge des pathologies dentaires et orthopédiques chez le cheval
20103015 Pharmaceuticals
Other subject
13 Mar 2024
08:55 CET
THERAVET
TheraVet : BIOCERA-VET® is Now Available for the Management of Dental and Orthopedics Conditions in Horses
20103015 Pharmaceuticals
Other subject
13 Mar 2024
07:30 CET
THERAVET
BIOCERA-VET® Is Now Available for the Management of Dental and Orthopedics Conditions in Horses
20103015 Pharmaceuticals
Other subject
13 Mar 2024
07:30 CET
THERAVET
BIOCERA-VET® est désormais disponible pour la prise en charge des pathologies dentaires et orthopédiques chez le cheval
20103015 Pharmaceuticals
Other subject
20 Feb 2024
07:30 CET
THERAVET
TheraVet mandate un cabinet de conseil vétérinaire américain de premier plan pour l’épauler dans l’élaboration de sa stratégie de croissance sur le marché américain
20103015 Pharmaceuticals
Other subject
20 Feb 2024
07:30 CET
THERAVET
TheraVet Retains a Leading US Veterinary Consulting Firm to Help Strategize Company Growth on the US Market
20103015 Pharmaceuticals
Other subject
30 Jan 2024
07:30 CET
THERAVET
TheraVet Strengthens Its Intellectual Property With the Issuance of a Patent on VISCO-VET Technology in Europe, Israël & Singapore
20103015 Pharmaceuticals
Other subject
30 Jan 2024
07:30 CET
THERAVET
TheraVet renforce sa propriété intellectuelle avec la délivrance d'un brevet sur la technologie VISCO-VET en Europe, Israël et Singapour
20103015 Pharmaceuticals
Other subject
23 Jan 2024
07:30 CET
THERAVET
TheraVet Reports an 99% Increase in BIOCERA-VET® Units Sold in Q4 2023
20103015 Pharmaceuticals
Other subject
23 Jan 2024
07:30 CET
THERAVET
TheraVet enregistre une croissance de 99% du nombre d‘unités vendues de BIOCERA-VET® au 4ème trimestre 2023
20103015 Pharmaceuticals
Other subject
17 Jan 2024
07:30 CET
THERAVET
TheraVet : Lancement commercial de BIOCERA-VET® en Allemagne
20103015 Pharmaceuticals
Other subject
17 Jan 2024
07:30 CET
THERAVET
TheraVet: Commercial Launch of BIOCERA-VET® in Germany
20103015 Pharmaceuticals
Other subject
09 Jan 2024
07:30 CET
THERAVET
TheraVet: Agreement with Alcyon Italia for the Distribution of BIOCERA-VET® Product Line in Italy
20103015 Pharmaceuticals
Other subject
09 Jan 2024
07:30 CET
THERAVET
TheraVet : Signature d'un accord avec Alcyon Italia pour la distribution de la ligne de produits BIOCERA-VET® en Italie
20103015 Pharmaceuticals
Other subject
04 Jan 2024
07:30 CET
THERAVET
TheraVet Reports Significant Success of Its Last Educational Webinar on Canine Osteosarcoma Co-Organized With Veterinary Instrumentation
20103015 Pharmaceuticals
Other subject
04 Jan 2024
07:30 CET
THERAVET
TheraVet annonce le succès significatif de son dernier webinaire éducatif consacré à l'ostéosarcome canin co-organisé avec Veterinary Instrumentation
20103015 Pharmaceuticals
Other subject
06 Dec 2023
07:30 CET
THERAVET
TheraVet annonce de nouvelles avancées pour son programme dédié à l'ostéosarcome
20103015 Pharmaceuticals
Other subject
06 Dec 2023
07:30 CET
THERAVET
TheraVet Reports Further Achievements on Its Osteosarcoma Program
20103015 Pharmaceuticals
Other subject
23 Nov 2023
07:30 CET
THERAVET
TheraVet : Lancement d’uneétude évaluant BIOCERA-VET® dans l'ostéosarcome canin menée par la prestigieuse Université de Floride
20103015 Pharmaceuticals
Other subject
23 Nov 2023
07:30 CET
THERAVET
TheraVet: Launch of BIOCERA-VET® Canine Osteosarcoma Study Conducted by the Prestigious University of Florida
20103015 Pharmaceuticals
Other subject
20 Nov 2023
18:00 CET
THERAVET
TheraVet annonce la mise en place d’une ligne de financement en capitaux propres et fait le point sur sa stratégie de financement
20103015 Pharmaceuticals
Other subject
20 Nov 2023
18:00 CET
THERAVET
TheraVet Announces the Setting up of an Equity-Linked Financing Facility and Updates on Its Financing Strategy
20103015 Pharmaceuticals
Other subject
08 Nov 2023
07:30 CET
THERAVET
TheraVet: Significant Sales Progression for BIOCERA-VET® in Q3 2023
20103015 Pharmaceuticals
Sales
08 Nov 2023
07:30 CET
THERAVET
TheraVet : Progression significative des ventes de la ligne BIOCERA-VET® au 3ème trimestre 2023
20103015 Pharmaceuticals
Sales
25 Oct 2023
07:30 CEST
THERAVET
TheraVet annonce la nomination d’un Directeur Financier et Administratif afin de renforcer sa stratégie globale de financement et de maitrise des coûts
20103015 Pharmaceuticals
Journal / appointments
25 Oct 2023
07:30 CEST
THERAVET
TheraVet Announces the Appointment of a Chief Financial Officer to Reinforce Its Global Financing and Cost Control Strategy
20103015 Pharmaceuticals
Journal / appointments
18 Oct 2023
07:30 CEST
THERAVET
TheraVet: Increasingly Successful Attendance in Major Ortho EU & US Conferences and North America Launch of BIOCERA-VET COMBO-CLEAN
20103015 Pharmaceuticals
Other subject
18 Oct 2023
07:30 CEST
THERAVET
TheraVet : Participation de plus en plus fructueuse aux principales conférences sur l'orthopédie en Europe et aux États-Unis et lancement de BIOCERA-VET COMBO-CLEAN en Amérique du Nord
20103015 Pharmaceuticals
Other subject
11 Oct 2023
07:30 CEST
THERAVET
TheraVet : Mise en évidence des propriétés de BIOCERA-VET dans le traitement des kystes osseux chez le cheval à l’occasion d'une conférence équine internationale aux États-Unis
20103015 Pharmaceuticals
Other subject
11 Oct 2023
07:30 CEST
THERAVET
TheraVet: BIOCERA-VET in Horse Bone Cysts Highlighted at an International Equine Conference in the USA
20103015 Pharmaceuticals
Other subject
27 Sep 2023
07:30 CEST
THERAVET
TheraVet: Patient Recruitment Phase Successfully Completed in BIOCERA-VET Fracture Revision Surgery Study in Toy Dogs
20103015 Pharmaceuticals
Other subject
27 Sep 2023
07:30 CEST
THERAVET
TheraVet : Succès de la phase de recrutement pour l'étude évaluant BIOCERA-VET dans la chirurgie de révision des fractures chez les chiens miniatures
20103015 Pharmaceuticals
Other subject
06 Sep 2023
07:30 CEST
THERAVET
TheraVet Reports Its 2023 Half-year Results and Provides an Update on the Development of Its Activities
20103015 Pharmaceuticals
Sales
06 Sep 2023
07:30 CEST
THERAVET
TheraVet publie ses résultats financiers du 1er semestre 2023 et fait le point sur le développement de ses activités
20103015 Pharmaceuticals
Sales
11 Jul 2023
07:30 CEST
THERAVET
TheraVet provides an update on its 2023 half-year development and portfolio strategy
20103015 Pharmaceuticals
New
11 Jul 2023
07:30 CEST
THERAVET
TheraVet fait le point sur son développement et sa stratégie de portefeuille au premier semestre 2023
20103015 Pharmaceuticals
New
15 Jun 2023
07:30 CEST
THERAVET
TheraVet annonce une augmentation de 300 % du nombre de centres participant au programme dédié à l’ostéosarcome depuis son lancement il y a six mois
20103015 Pharmaceuticals
Other subject
15 Jun 2023
07:30 CEST
THERAVET
TheraVet Announces 300% Increase in Participating Centers in the Osteosarcoma Program Since Its Initiation 6 Months Ago
20103015 Pharmaceuticals
Other subject
31 May 2023
07:30 CEST
THERAVET
TheraVet annonce le lancement commercial d'un substitut osseux à libération locale et prolongée d'antibiotiques
20103015 Pharmaceuticals
Products and services
31 May 2023
07:30 CEST
THERAVET
TheraVet Announces the Commercial Launch of a Local and Sustained Antibiotic Releasing Bone Substitute
20103015 Pharmaceuticals
Products and services
04 May 2023
07:30 CEST
THERAVET
TheraVet Continues the Assessment of BIOCERA-VET in a New Clinical Program
20103015 Pharmaceuticals
Other subject
04 May 2023
07:30 CEST
THERAVET
TheraVet poursuit l'évaluation de BIOCERA-VET dans un nouveau programme clinique
20103015 Pharmaceuticals
Other subject
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
1
2
3
›
››
»
Last »
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva